Cargando…
Chemogenetic activation of locus coeruleus neurons ameliorates the severity of multiple sclerosis
BACKGROUND: Most current disease-modifying therapies approved for multiple sclerosis (MS) are immunomodulatory drugs that counteract the aberrant activity of the immune system. Hence, new pharmacological interventions that drive anti-inflammatory activity and neuroprotection would represent interest...
Autores principales: | Torrillas-de la Cal, Alejandro, Torres-Sanchez, Sonia, Bravo, Lidia, Llorca-Torralba, Meritxell, Garcia-Partida, Jose Antonio, Arroba, Ana I., Berrocoso, Esther |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474779/ https://www.ncbi.nlm.nih.gov/pubmed/37658434 http://dx.doi.org/10.1186/s12974-023-02865-z |
Ejemplares similares
-
Pain and depression comorbidity causes asymmetric plasticity in the locus coeruleus neurons
por: Llorca-Torralba, Meritxell, et al.
Publicado: (2021) -
Sexual differences in locus coeruleus neurons and related behavior in C57BL/6J mice
por: Mariscal, Patricia, et al.
Publicado: (2023) -
Altered expression of vesicular glutamate transporter-2 and cleaved caspase-3 in the locus coeruleus of nerve-injured rats
por: Bravo, Lidia, et al.
Publicado: (2022) -
Monoamines as Drug Targets in Chronic Pain: Focusing on Neuropathic Pain
por: Bravo, Lidia, et al.
Publicado: (2019) -
Sustained chemogenetic activation of locus coeruleus norepinephrine neurons promotes dopaminergic neuron survival in synucleinopathy
por: Jovanovic, Predrag, et al.
Publicado: (2022)